Literature DB >> 1700672

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

C Tetta1, G Camussi, V Modena, C Di Vittorio, C Baglioni.   

Abstract

Fifteen serum samples and 29 synovial fluids of patients with rheumatoid arthritis (RA) were examined for the presence of tumour necrosis factor (TNF). The assay for TNF was based on the cytotoxic activity of this cytokine for human melanoma cells in tissue culture. High concentrations of TNF were found in serum samples of patients with severe RA, who had increased erythrocyte sedimentation rate and serum alpha 2 macroglobulin, but decreased haemoglobin and serum iron concentrations. Tumour necrosis factor was also found in the synovial fluid of 16 out of 29 patients. High TNF concentrations were found in fluids with greater than 10(10) leucocytes/l. Tumour necrosis factor was not detected in the serum of normal subjects or in synovial fluid of patients with osteoarthritis. A mediator of inflammation, such as TNF, may contribute to the severity of RA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700672      PMCID: PMC1004199          DOI: 10.1136/ard.49.9.665

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

Authors:  D R Bertolini; G E Nedwin; T S Bringman; D D Smith; G R Mundy
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 4.  NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.

Authors:  J L Decker; D G Malone; B Haraoui; S M Wahl; L Schrieber; J H Klippel; A D Steinberg; R L Wilder
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

5.  Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.

Authors:  V Ruggiero; K Latham; C Baglioni
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

6.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors:  T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal:  Arthritis Rheum       Date:  1988-08

8.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

9.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors:  J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

2.  Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Authors:  A K Ulfgren; L Gröndal; S Lindblad; M Khademi; O Johnell; L Klareskog; U Andersson
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

3.  Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.

Authors:  Cindy Zer; George Sachs; Jai Moo Shin
Journal:  Physiol Genomics       Date:  2007-07-24       Impact factor: 3.107

4.  Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.

Authors:  Ankit Mahendra; Xingyu Yang; Shaza Abnouf; Jay R T Adolacion; Daechan Park; Sanam Soomro; Jason Roszik; Cristian Coarfa; Gabrielle Romain; Keith Wanzeck; S Louis Bridges; Amita Aggarwal; Peng Qiu; Sandeep K Agarwal; Chandra Mohan; Navin Varadarajan
Journal:  Arthritis Rheumatol       Date:  2019-02-23       Impact factor: 10.995

Review 5.  The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.

Authors:  G Camussi; E Lupia
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

6.  Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.

Authors:  Maria Jakobsen; Karin Stenderup; Cecilia Rosada; Brian Moldt; Søren Kamp; Tomas N Dam; Thomas G Jensen; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

7.  Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction.

Authors:  Xuewen Wang; Xingshen Zhao; Shusen Tang
Journal:  Cell Stress Chaperones       Date:  2015-06-05       Impact factor: 3.667

Review 8.  The role of lymphotoxin-α in rheumatoid arthritis.

Authors:  Tomohiro Hirose; Yuri Fukuma; Ayumu Takeshita; Keiichiro Nishida
Journal:  Inflamm Res       Date:  2018-03-14       Impact factor: 4.575

9.  Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.

Authors:  B A Eberhard; R M Laxer; U Andersson; E D Silverman
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.

Authors:  V A Danis; G M Franic; D A Rathjen; R M Laurent; P M Brooks
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.